{"id":249063,"date":"2024-06-07T14:22:14","date_gmt":"2024-06-07T13:22:14","guid":{"rendered":"https:\/\/www.futurecobioscience.com\/?p=249063"},"modified":"2026-01-30T12:26:03","modified_gmt":"2026-01-30T11:26:03","slug":"new-patent-for-bionematicide","status":"publish","type":"post","link":"https:\/\/www.futurecobioscience.com\/en\/new-patent-for-bionematicide\/","title":{"rendered":"Futureco Bioscience obtains European Patent for new microbial bionematicide"},"content":{"rendered":"\n<p>This innovation leverages on the <strong>potent bionematicide activity<\/strong> of strain B410 of <em>Metabacillus halosaccharovorans<\/em>. Preliminary studies in growth chambers, greenhouses, and fields show high nematicidal activity against four species of the <em>Meloidogyne genus <\/em>and two species of the <em>Globodera genus<\/em>. These are two of the most widespread and economically significant genera. This research promises an eco-friendly solution to combat nematodes and protect crop yields. Given that <strong>global annual losses due to nematodes are estimated at $157 billion<\/strong>, this bionematicide technology marks a significant progress in sustainable nematodes management.<\/p>\n\n\n\n<p><strong><em>Ol\u00e9rdola, Barcelona. (Spain) &#8211; May 21, 2024.<\/em><\/strong> &#8211; Futureco Bioscience, a Spanish biotechnological company that specializes in <strong>researching, developing, and manufacturing biological products<\/strong>, has been granted from the <a href=\"https:\/\/www.oepm.es\/es\/sobre-OEPM\/nosotros\/cooperacion-regiones-y-organizaciones-internacionales\/con-la-oficina-europea-de-patentes-OEP\/\" target=\"_blank\" rel=\"noopener\">European Patent Office<\/a> a <strong>new patent<\/strong> (EP 3934428 B1) for a new <strong>microbial bionematicide<\/strong> technology. This patented bionematicide underscores Futureco Bioscience&#8217;s investment in research and innovation and the company significant role in advancing the biocontrol and bionematcide manufacturing industry.<\/p>\n\n\n\n<p>This patent recognizes the innovative strain B410 of <em>Metabacillus halosaccharovorans<\/em>, isolated from organic farming soil in Almer\u00eda (Spain). This strain exhibits strong <strong>bionematicide properties<\/strong>, positioning it as a promising active ingredient for biological nematode control. Its mesophilic, neutrophilic, and halotolerant characteristics, together with robust biofilm production, enhance the performance and persistence of this <strong>bionematicide<\/strong> under challenging agricultural conditions, particularly in arid and saline environments.<\/p>\n\n\n\n<p>While studies are still ongoing, preliminary results have shown that <strong>this strain notably inhibits the hatching of nematode eggs<\/strong>. Its <strong>bionematicide effectiveness<\/strong> is especially notable against root-knot nematodes (RKN) <em>Meloidogyne incognita<\/em>, <em>M. javanica<\/em>, <em>M. arenaria<\/em>, and <em>M. hapla<\/em> as well as and potato cyst nematodes (PCN) <em>Globodera rostochiensis <\/em>and <em>Globodera pallida<\/em>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/www.futurecobioscience.com\/wp-content\/uploads\/2024\/06\/Nueva-patente-nematicida-Futureco-Bioscience-1-1024x768.jpg\" alt=\"New-patent-for-bionematicide-Futureco-Bioscience\" class=\"wp-image-249059\" srcset=\"https:\/\/www.futurecobioscience.com\/wp-content\/uploads\/2024\/06\/Nueva-patente-nematicida-Futureco-Bioscience-1-1024x768.jpg 1024w, https:\/\/www.futurecobioscience.com\/wp-content\/uploads\/2024\/06\/Nueva-patente-nematicida-Futureco-Bioscience-1-300x225.jpg 300w, https:\/\/www.futurecobioscience.com\/wp-content\/uploads\/2024\/06\/Nueva-patente-nematicida-Futureco-Bioscience-1-768x576.jpg 768w, https:\/\/www.futurecobioscience.com\/wp-content\/uploads\/2024\/06\/Nueva-patente-nematicida-Futureco-Bioscience-1-1536x1152.jpg 1536w, https:\/\/www.futurecobioscience.com\/wp-content\/uploads\/2024\/06\/Nueva-patente-nematicida-Futureco-Bioscience-1-2048x1536.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>The first formulation of this <strong>bionematicide active ingredient<\/strong> has been developed as an Oil Dispersion (OD), that ensures a <strong>finely stable dispersion of the active ingredient<\/strong> in a water immiscible solvent. Formulation has been obtained by scalable manufacturing approach using state-of-the-art liquid fermentation technology, designed to maintain a high concentration of the active microorganism, which allowed to achieve levels in the range of 109 CFU\/mL.<\/p>\n\n\n\n<p>Carolina Fernandez, <a href=\"https:\/\/www.futurecobioscience.com\/en\/rdi-biostimulant-biopesticide\/\">R&amp;D<\/a> Director at Futureco Bioscience, commented: \u201c<strong>Currently, there are no truly effective nematicide products<\/strong>, whether biological or chemical, that can adequately address the issues plaguing the sector. This is largely due to the complex ecosystem in which these diseases thrive: the soil. The nematode-nematicide pairing and the treatment&#8217;s effectiveness are influenced by soil complex characteristics (type, texture, structure, aeration, moisture content, pH, etc.) and the microbiome proliferating within it. Moreover, each ecosystem has unique populations and species, and a nematicide&#8217;s efficacy may vary under field and geographical conditions.\u201d Fernandez continued,<strong> &#8220;It&#8217;s crucial to test a microorganism&#8217;s potential nematicide activity under a broad range of diverse conditions in vitro, then in climatic chambers and greenhouses before field trials<\/strong>. In particular settings, we expect the effectiveness to be compromised to a certain degree. Fortunately, at Futureco Bioscience, <strong>our facilities allow us to replicate and test a wide range of scenarios, so we only bring solid and reliable results to the field<\/strong>.\u201d<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">The dual impact of nematodes: why bionematicides are becoming essential in modern agriculture<\/h2>\n\n\n\n<p>The growing economic impact of plant-parasitic nematodes has accelerated interest in sustainable solutions such as <strong>bionematicides<\/strong>. <strong>Global annual losses <\/strong>due to nematodes are estimated at approximately <strong>$157 billion (12% of global agricultural production worldwide)<\/strong>. These losses stem from crop damage, reduced yields, and increased production costs. In addition to crop damage, nematode infestations can increase production costs by requiring the use of costly management strategies, such as chemical control. This can add to the financial burden of farmers, particularly those in developing nations with limited resources.<\/p>\n\n\n\n<p>Simultaneously, <a href=\"https:\/\/www.thebusinessresearchcompany.com\/\" target=\"_blank\" rel=\"noopener\">The Business Research Company<\/a>&#8216;s Nematicides Global Market Report 2024 a<strong>nticipates significant growth in the nematicides market<\/strong>, that it\u2019s expected to reach <strong>$2.31 billion by 2028<\/strong>, with biological solutions and <strong>bionematicides<\/strong> playing a central role in market growth. Factors driving this growth include the expansion of organic farming, precision agriculture, and the impact of climate change. In this sense, merging trends encompass sustainable agriculture certification, bionematicides, research and innovation, data-driven decision-making, and chemical nematicides.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This innovation leverages on the potent bionematicide activity of strain B410 of Metabacillus halosaccharovorans. Preliminary studies in growth chambers, greenhouses, and fields show high nematicidal activity against four species of the Meloidogyne genus and two species of the Globodera genus. These are two of the most widespread and economically significant genera. This research promises an [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":249064,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[61],"tags":[212,213,211],"class_list":["post-249063","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press","tag-biocontrol","tag-biological-control","tag-bionematicide"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.futurecobioscience.com\/en\/wp-json\/wp\/v2\/posts\/249063","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.futurecobioscience.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.futurecobioscience.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.futurecobioscience.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.futurecobioscience.com\/en\/wp-json\/wp\/v2\/comments?post=249063"}],"version-history":[{"count":2,"href":"https:\/\/www.futurecobioscience.com\/en\/wp-json\/wp\/v2\/posts\/249063\/revisions"}],"predecessor-version":[{"id":254273,"href":"https:\/\/www.futurecobioscience.com\/en\/wp-json\/wp\/v2\/posts\/249063\/revisions\/254273"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.futurecobioscience.com\/en\/wp-json\/wp\/v2\/media\/249064"}],"wp:attachment":[{"href":"https:\/\/www.futurecobioscience.com\/en\/wp-json\/wp\/v2\/media?parent=249063"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.futurecobioscience.com\/en\/wp-json\/wp\/v2\/categories?post=249063"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.futurecobioscience.com\/en\/wp-json\/wp\/v2\/tags?post=249063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}